These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

679 related articles for article (PubMed ID: 33027962)

  • 1. Cellular and Molecular Mechanisms of CD8
    Verdon DJ; Mulazzani M; Jenkins MR
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33027962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Combination of Anti-PD-L1 Treatment and Therapeutic Vaccination Facilitates Improved Retroviral Clearance via Reactivation of Highly Exhausted T Cells.
    Knuschke T; Kollenda S; Wenzek C; Zelinskyy G; Steinbach P; Dittmer U; Buer J; Epple M; Westendorf AM
    mBio; 2021 Feb; 12(1):. PubMed ID: 33531395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD8 T Cell Exhaustion in Chronic Infection and Cancer: Opportunities for Interventions.
    Hashimoto M; Kamphorst AO; Im SJ; Kissick HT; Pillai RN; Ramalingam SS; Araki K; Ahmed R
    Annu Rev Med; 2018 Jan; 69():301-318. PubMed ID: 29414259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD8
    Kurachi M
    Semin Immunopathol; 2019 May; 41(3):327-337. PubMed ID: 30989321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developmental Relationships of Four Exhausted CD8
    Beltra JC; Manne S; Abdel-Hakeem MS; Kurachi M; Giles JR; Chen Z; Casella V; Ngiow SF; Khan O; Huang YJ; Yan P; Nzingha K; Xu W; Amaravadi RK; Xu X; Karakousis GC; Mitchell TC; Schuchter LM; Huang AC; Wherry EJ
    Immunity; 2020 May; 52(5):825-841.e8. PubMed ID: 32396847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exhaustion of the CD8
    Wentink MWJ; Mueller YM; Dalm VASH; Driessen GJ; van Hagen PM; van Montfrans JM; van der Burg M; Katsikis PD
    Front Immunol; 2018; 9():446. PubMed ID: 29563914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Precursor exhausted T cells: key to successful immunotherapy?
    Kallies A; Zehn D; Utzschneider DT
    Nat Rev Immunol; 2020 Feb; 20(2):128-136. PubMed ID: 31591533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human effector CD8
    Mietz J; Kaulfuss M; Egli L; Opitz L; Münz C; Chijioke O
    EBioMedicine; 2024 Aug; 106():105240. PubMed ID: 38986249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity and fate choice: T cell exhaustion in cancer and chronic infections.
    Philip M; Schietinger A
    Curr Opin Immunol; 2019 Jun; 58():98-103. PubMed ID: 31181510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subsets of exhausted CD8
    Miller BC; Sen DR; Al Abosy R; Bi K; Virkud YV; LaFleur MW; Yates KB; Lako A; Felt K; Naik GS; Manos M; Gjini E; Kuchroo JR; Ishizuka JJ; Collier JL; Griffin GK; Maleri S; Comstock DE; Weiss SA; Brown FD; Panda A; Zimmer MD; Manguso RT; Hodi FS; Rodig SJ; Sharpe AH; Haining WN
    Nat Immunol; 2019 Mar; 20(3):326-336. PubMed ID: 30778252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional regulatory network for the establishment of CD8
    Seo W; Jerin C; Nishikawa H
    Exp Mol Med; 2021 Feb; 53(2):202-209. PubMed ID: 33627794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intratumoral Tcf1
    Siddiqui I; Schaeuble K; Chennupati V; Fuertes Marraco SA; Calderon-Copete S; Pais Ferreira D; Carmona SJ; Scarpellino L; Gfeller D; Pradervand S; Luther SA; Speiser DE; Held W
    Immunity; 2019 Jan; 50(1):195-211.e10. PubMed ID: 30635237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of Mass Cytometry to Profile Human T Cell Exhaustion.
    Winkler F; Bengsch B
    Front Immunol; 2019; 10():3039. PubMed ID: 32038613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel targets for immunotherapy associated with exhausted CD8 + T cells in cancer.
    Zhang L; Zhang B; Li L; Ye Y; Wu Y; Yuan Q; Xu W; Wen X; Guo X; Nian S
    J Cancer Res Clin Oncol; 2023 May; 149(5):2243-2258. PubMed ID: 36107246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exhausted CD8+T Cells in the Tumor Immune Microenvironment: New Pathways to Therapy.
    Jiang W; He Y; He W; Wu G; Zhou X; Sheng Q; Zhong W; Lu Y; Ding Y; Lu Q; Ye F; Hua H
    Front Immunol; 2020; 11():622509. PubMed ID: 33633741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Premature terminal exhaustion of Friend virus-specific effector CD8+ T cells by rapid induction of multiple inhibitory receptors.
    Takamura S; Tsuji-Kawahara S; Yagita H; Akiba H; Sakamoto M; Chikaishi T; Kato M; Miyazawa M
    J Immunol; 2010 May; 184(9):4696-707. PubMed ID: 20351188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD8 T-cell heterogeneity during T-cell exhaustion and PD-1-targeted immunotherapy.
    Ando S; Araki K
    Int Immunol; 2022 Oct; 34(11):571-577. PubMed ID: 35901837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD8
    Dolina JS; Van Braeckel-Budimir N; Thomas GD; Salek-Ardakani S
    Front Immunol; 2021; 12():715234. PubMed ID: 34354714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role, function and regulation of the thymocyte selection-associated high mobility group box protein in CD8
    Cheng Y; Shao Z; Chen L; Zheng Q; Zhang Q; Ding W; Zhang M; Yu Q; Gao D
    Immunol Lett; 2021 Jan; 229():1-7. PubMed ID: 33186634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell differentiation in chronic infection and cancer: functional adaptation or exhaustion?
    Speiser DE; Utzschneider DT; Oberle SG; Münz C; Romero P; Zehn D
    Nat Rev Immunol; 2014 Nov; 14(11):768-74. PubMed ID: 25257362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.